Reagents that bind CCX-CKR2

Details for Australian Patent Application No. 2006238855 (hide)

Owner Chemocentryx, Inc.

Inventors Schall, Thomas; Howard, Maureen

Agent Spruson & Ferguson

Pub. Number AU-B-2006238855

PCT Pub. Number WO2006/116319

Priority 60/674,140 21.04.05 US

Filing date 19 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 22 December 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116319 Priority application(s): WO2006/116319

22 December 2011 Application Accepted

  Published as AU-B-2006238855

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006238858-Nicotinamide riboside kinase compositions and methods for using the same

2006238853-Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments